Erste Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-6,649
Closed -$121K 575
2023
Q4
$147K Hold
6,649
﹤0.01% 495
2023
Q3
$123K Hold
6,649
﹤0.01% 495
2023
Q2
$168K Hold
6,649
﹤0.01% 501
2023
Q1
$162K Hold
6,649
﹤0.01% 506
2022
Q4
$159K Hold
6,649
﹤0.01% 519
2022
Q3
$174K Hold
6,649
﹤0.01% 505
2022
Q2
$228K Hold
6,649
0.01% 505
2022
Q1
$486K Buy
6,649
+750
+13% +$54K 0.01% 439
2021
Q4
$532K Buy
5,899
+2,145
+57% +$256K 0.01% 422
2021
Q3
$473K Buy
+3,754
New +$547K 0.01% 422

Other funds holding TDOC

Erste Asset Management's TDOC Position: Q1 2024 in Review

Erste Asset Management sold out of Teladoc Health (TDOC) in Q1 2024, closing a stake of 6,649 shares — an estimated $121K sold.

Erste Asset Management first reported a position in TDOC in Q3 2021 and held it in 10 quarters. The position peaked at $532K in Q4 2021. 426 funds tracked by Wall St. Rank hold TDOC as of Q1 2024.

  • Erste Asset Management reported no remaining Teladoc Health position as of Q1 2024 after selling out during the quarter.
  • Erste Asset Management sold 6,649 Teladoc Health shares in Q1 2024, an estimated $121K.
  • Erste Asset Management first reported a position in Teladoc Health in Q3 2021 and held it in 10 quarters.
  • Erste Asset Management's Teladoc Health position peaked at $532K in Q4 2021.
  • 426 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.